Targeting epigenetic dysregulation in bladder cancer through inhibition of EZH2.

被引：0
|
作者：
Keller, Patricia J. [1 ]
Meyer, Rosana [1 ]
Greenwald, Emily [1 ]
Han, Xinwei [1 ]
Conery, Andrew R. [1 ]
Mertz, Jennifer A. [1 ]
Trojer, Patrick [1 ]
机构：
[1] Pharmaceut Inc, Cambridge, MA USA
来源：
CLINICAL CANCER RESEARCH | 2020年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A18
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [31] Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
    Huang, Xun
    Yan, Juan
    Zhang, Min
    Wang, Yafang
    Chen, Yi
    Fu, Xuhong
    Wei, Rongrui
    Zheng, Xing-ling
    Liu, Zhiwei
    Zhang, Xiong
    Yang, Hong
    Hao, Bingbing
    Shen, Yan-yan
    Su, Yi
    Cong, Xiaoji
    Huang, Min
    Tan, Minjia
    Ding, Jian
    Geng, Meiyu
    CELL, 2018, 175 (01) : 186 - +
  • [32] Targeting epigenetic crosstalk as a therapeutic strategy for EZH2-aberrant solid tumors
    Huang, X.
    Yan, J.
    Zhang, M.
    Wang, Y.
    Tan, M.
    Ding, J.
    Geng, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E5 - E5
  • [33] EZH2 in Bladder Cancer, a Promising Therapeutic Target
    Martinez-Fernandez, Monica
    Rubio, Carolina
    Segovia, Cristina
    Lopez-Calderon, Fernando F.
    Duenas, Marta
    Paramio, Jesus M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (11): : 27107 - 27132
  • [34] Targeting EZH2 for Cancer Therapy: Progress and Perspective
    Li, Chi Han
    Chen, Yangchao
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2015, 16 (06) : 559 - 570
  • [35] Targeting histone methyltransferase EZH2 as cancer treatment
    Kondo, Yutaka
    JOURNAL OF BIOCHEMISTRY, 2014, 156 (05): : 249 - 257
  • [36] Dual inhibition of EZH2 and histone deacetylases for the treatment of lymphomas with epigenetic aberrations
    Mensah, Afua Adjeiwaa
    Valente, Sergio
    Matkovic, Milos
    Sartori, Giulio
    Falzarano, Chiara
    Tarantelli, Chiara
    Cascione, Luciano
    Pileri, Stefano A.
    Cavalli, Andrea
    Mai, Antonello
    Bertoni, Francesco
    CANCER RESEARCH, 2022, 82 (12)
  • [37] Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells
    Wang, H. F.
    Yang, H.
    Hu, L. B.
    Lei, Y. H.
    Qin, Y.
    Li, J.
    Bi, C. W.
    Wang, J. S.
    Huo, Q.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (04) : 9939 - 9950
  • [38] A pre-clinical organoid model to select suitable bladder cancer patients for targeting EZH2 treatment
    Zhao, H.
    Liao, J.
    Liu, K.
    Chen, X.
    Wu, H.
    Chiu, P. K-F
    Ng, C-F
    Teoh, J. Y-C
    EUROPEAN UROLOGY, 2024, 85 : S1501 - S1501
  • [39] The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer
    Friedman, Jeffrey M.
    Jones, Peter A.
    Liang, Gangning
    CELL CYCLE, 2009, 8 (15) : 2313 - 2314
  • [40] A PRE-CLINICAL ORGANOID MODEL TO SELECT SUITABLE BLADDER CANCER PATIENTS FOR TARGETING EZH2 TREATMENT
    Zhao, Hongda
    Liao, Jason
    Liu, Kang
    Chen, Xuan
    Wu, Hongwei
    Chiu, Peter Ka-Fung Chiu
    Ng, Chi-Fai
    Teoh, Jeremy Yuen-Chun
    JOURNAL OF UROLOGY, 2024, 211 (05): : E232 - E232
12345